Latest News
London open: Stocks fall amid earnings deluge
London stocks fell in early trade on Thursday as investors waded through a deluge of corporate news and mulled the latest policy announcement from the US Federal Reserve.
Greencoat UK Wind generation ahead of budget in first half
Greencoat UK Wind said on Thursday that its investments generated 1,494GWh of electricity in the first half, which was 2% ahead of budget, with a high wind resource in the first quarter being partially offset by a low wind resource in the second quarter.
Healthcare and defence sectors help bolster Morgan Advanced Materials
Morgan Advanced Materials reported an 8. 8% fall in revenue on an organic, constant currency basis in its first half on Thursday, to £477. 8m, as its financial guidance remained suspended.
Kaz maintains production guidance, though Covid risks linger
Kaz Minerals reported first half copper production of 153. 8 kt on Thursday, up 4% year-on-year, which it said was driven by high ore throughput and improved grades at Bozshakol.
Inchcape to cut jobs as Covid shutdowns force first-half loss
Car dealer Inchcape said it would be cutting jobs globally as it swung to a first-half loss due to Covid-19 shutdowns.
Evraz warns of 'uncertainty' around FY output and sales
Shares in mining group Evraz were under pressure in early trading on Thursday after the group warned of "uncertainty" around output and sales amid ongoing turmoil in oil and gas markets.
Schroders grows AuM over 1H, interim payout steady
Schroders's bottom line took a hit during the front half of the year, but the fund manager saw net inflows and assets under management grow despite the challenging environment.
Man Group H1 FuM decline 8% after 'challenging' period
Man Group reported an 8% decline in first-half funds under management on Thursday and a drop in pre-tax profit following a "challenging time".
Compass Group seeing 'slow recovery' as revenue slides
Compass Group reported a 44% fall in organic revenue in its third quarter on Thursday, with revenue down 14% year-on-year in the first nine months overall.
AstraZeneca maintains guidance after first-half growth
AstraZeneca reported a 12% rise in total revenue in its first half on Thursday, or 14% at constant exchange rates, to $12. 63bn (£9. 75bn), with growth across all three of its therapy areas and in all of its regions.
Rentokil interim profit hit by Covid-19 closures
Pest control and hygiene services company Rentokil posted a decline in interim profit on Thursday as it took a hit from the temporary closure of some businesses due to the coronavirus lockdown.
Shell swings to loss on $16bn impairment charge but pays dividend
Royal Dutch Shell swung to a heavy net first-half loss, but paid a dividend as the Covid-19 crisis hammered oil and gas prices.
Lloyds Bank increases bad debt provision, AstraZeneca maintains full-year guidance
London open The FTSE 100 is expected to open 12 points higher on Thursday, having closed up 0. 036% at 6,131. 46 on Wednesday.
London pre-open: Stocks to edge up ahead of earnings deluge
London stocks were set to edge higher on Thursday following a positive US close, as investors braced for a deluge of earnings news.
Thursday newspaper round-up: Covid-19 rescue loan scheme, UK car production, Monsoon
The government is expanding its Covid-19 rescue loan scheme to cover small businesses on the edge of collapse, a move that Labour warned would come too late for many troubled firms. With less than a week before the furlough scheme covering 9 million employees is cut back, plunging more employers into debt, the Treasury said it would use a change in EU state aid rules to allow firms previously locked out of the coronavirus business interruption loan scheme (CBILS) to access government funds.
US close: Stocks finish higher as Fed stands pat on rates
US stocks closed slightly higher on Wednesday as market participants digested the latest from the Federal Reserve, as it stood pat on interest rates late in the day.